NCBI . NLM . NIH . GOV {}

Matching Content Categories {📚}

• Education
• Insurance
• Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We find it hard to spot revenue streams.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Ncbi.nlm.nih.gov might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

doi, neoadjuvant, cancer, study, patients, lung, google, scholar, pubmed, chemotherapy, reported, mpr, studies, resectable, nsclc, pathological, surgical, rates, pmc, response, article, safety, pcr, free, cohort, nivolumab, stage, resection, immunotherapy, included, singlearm, traes, ici, cycles, durvalumab, efficacy, delay, chemo, trials, immune, icis, data, phase, cell, systematic, grade, oncol, nonsmall, arm, trial,

Topics {✒️}

supplementary tables s1 small-cell lung cancers small-cell lung cancer cd8+ tumor-infiltrating lymphocytes squamous cell carcinoma kras-mutant lung adenocarcinoma free text words long-term tumor control pmc beta search supplementary materials included single-arm cohort study treatment-related adverse events 10 supplementary table s4 single-arm cohort studies primary endpoints monotherapy–ici publisher site pdf event-free survival [google scholar] 14 [google scholar] 18 [google scholar] 19 [google scholar] 30 progression-free survival license information pmcid response evaluation criteria adverse events related monotherapy–ici group locally advanced stage supplementary table s3 clin lung cancer resectable lung cancer immune-related aes high-risk resectable melanoma chemotherapy–ici group advanced stage nsclc stage iv nsclc stage i-iiia pathologically diagnosed nsclc locally advanced nsclc immune checkpoint blockade lung resection specimens annual meetings held tumor molecular contexture immune checkpoint inhibitors dual–ici cohort single study arm clin cancer res chemotherapy versus monotherapy monotherapy–ici cohort phase ii trial resected lung carcinomas

Social Networks {👍}(6)

• https://twitter.com/ncbi
• https://www.facebook.com/ncbi.nlm
• https://www.linkedin.com/company/ncbinlm
• https://twitter.com/nlm_nih
• https://www.facebook.com/nationallibraryofmedicine
• https://www.youtube.com/user/NLMNIH

External Links {🔗}(90)

• What are the total earnings of https://doi.org/10.1016/j.esmoop.2021.100244?
• How much does https://doi.org/10.1016/j.jtho.2015.09.009 pull in monthly?
• https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&title=The%20IASLC%20Lung%20Cancer%20Staging%20Project:%20proposals%20for%20revision%20of%20the%20TNM%20stage%20groupings%20in%20the%20forthcoming%20(eighth)%20edition%20of%20the%20TNM%20classification%20for%20lung%20cancer&author=P.%20Goldstraw&author=K.%20Chansky&author=J.%20Crowley&volume=11&issue=1&publication_year=2016&pages=39-51&pmid=26762738&doi=10.1016/j.jtho.2015.09.009& income
• Earnings of https://doi.org/10.3978/j.issn.2218-6751.2013.10.05
• Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Transl%20Lung%20Cancer%20Res&title=Prognostic%20and%20predictive%20biomarkers%20in%20early%20stage%20non-small%20cell%20lung%20cancer:%20tumor%20based%20approaches%20including%20gene%20signatures&author=S.%20Carnio&author=S.%20Novello&author=M.%20Papotti&author=M.%20Loiacono&author=G.V.%20Scagliotti&volume=2&issue=5&publication_year=2013&pages=372-381&pmid=25806256&doi=10.3978/j.issn.2218-6751.2013.10.05&
• How much profit is https://doi.org/10.3978/j.issn.2218-6751.2013.12.05 making per month?
• What is the earnings of https://scholar.google.com/scholar_lookup?journal=Transl%20Lung%20Cancer%20Res&title=Recurrence%20after%20surgery%20in%20patients%20with%20NSCLC&author=H.%20Uramoto&author=F.%20Tanaka&volume=3&issue=4&publication_year=2014&pages=242-249&pmid=25806307&doi=10.3978/j.issn.2218-6751.2013.12.05&?
• Learn about the earnings of https://doi.org/10.1016/S0140-6736(13)62159-5
• What's the financial gain of https://scholar.google.com/scholar_lookup?journal=Lancet&title=Preoperative%20chemotherapy%20for%20non-small-cell%20lung%20cancer:%20a%20systematic%20review%20and%20meta-analysis%20of%20individual%20participant%20data&volume=383&issue=9928&publication_year=2014&pages=1561-1571&pmid=24576776&doi=10.1016/S0140-6736(13)62159-5&?
• What's the revenue for https://doi.org/10.1038/s41591-020-01188-3?
• What's the income of https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Pathological%20response%20and%20survival%20with%20neoadjuvant%20therapy%20in%20melanoma:%20a%20pooled%20analysis%20from%20the%20International%20Neoadjuvant%20Melanoma%20Consortium%20(INMC)&author=A.M.%20Menzies&author=R.N.%20Amaria&author=E.A.%20Rozeman&volume=27&issue=2&publication_year=2021&pages=301-309&pmid=33558722&doi=10.1038/s41591-020-01188-3&?
• What's the monthly income of https://doi.org/10.1038/s41591-018-0197-1?
• Learn how profitable https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Neoadjuvant%20immune%20checkpoint%20blockade%20in%20high-risk%20resectable%20melanoma&author=R.N.%20Amaria&author=S.M.%20Reddy&author=H.A.%20Tawbi&volume=24&issue=11&publication_year=2018&pages=1649-1654&pmid=30297909&doi=10.1038/s41591-018-0197-1& is on a monthly basis
• What's the total monthly financial gain of https://doi.org/10.1056/NEJMoa1504030?
• How much does https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&title=Combined%20nivolumab%20and%20ipilimumab%20or%20monotherapy%20in%20untreated%20melanoma&author=J.%20Larkin&author=V.%20Chiarion-Sileni&author=R.%20Gonzalez&volume=373&issue=1&publication_year=2015&pages=23-34&pmid=26027431&doi=10.1056/NEJMoa1504030& net monthly?
• How much income does https://doi.org/10.1158/1078-0432.CCR-19-3255 have?
• What's the financial intake of https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Current%20panorama%20and%20challenges%20for%20neoadjuvant%20cancer%20immunotherapy&author=J.C.%20Benitez&author=J.%20Remon&author=B.%20Besse&volume=26&publication_year=2020&pages=5068-5077&pmid=32434852&doi=10.1158/1078-0432.CCR-19-3255&?
• Financial intake of https://doi.org/10.1371/journal.pmed.1000100
• Explore the financials of https://scholar.google.com/scholar_lookup?journal=PLoS%20Med&title=The%20PRISMA%20statement%20for%20reporting%20systematic%20reviews%20and%20meta-analyses%20of%20studies%20that%20evaluate%20health%20care%20interventions:%20explanation%20and%20elaboration&author=A.%20Liberati&author=D.G.%20Altman&author=J.%20Tetzlaff&volume=6&issue=7&publication_year=2009&pages=e1000100&pmid=19621070&doi=10.1371/journal.pmed.1000100&
• How much revenue does https://www.abstractsonline.com/pp8/#!/9325/presentation/5134 bring in?
• Revenue of https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&title=1215O%C2%A0%E2%88%92%20SC%20neoadjuvant%20atezolizumab%20(A)%20for%20resectable%20non-small%20cell%20lung%20cancer%20(NSCLC):%20results%20from%20the%20phase%20II%20PRINCEPS%20trial&author=B.%20Besse&author=J.%20Adam&author=N.%20Cozic&volume=31&publication_year=2020&pages=S794-S795&
• What are the earnings of https://doi.org/10.1016/j.lungcan.2021.01.018?
• How much income is https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&title=Neoadjuvant%20anti-programmed%20death-1%20immunotherapy%20by%20pembrolizumab%20in%20resectable%20non-small%20cell%20lung%20cancer:%20first%20clinical%20experience&author=F.%20Eichhorn&author=L.V.%20Klotz&author=M.%20Kriegsmann&volume=153&publication_year=2021&pages=150-157&pmid=33529989&doi=10.1016/j.lungcan.2021.01.018& earning monthly?
• What's the income generated by https://doi.org/10.1056/NEJMoa1716078 each month?
• Earnings of https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&title=Neoadjuvant%20PD-1%20blockade%20in%20resectable%20lung%20cancer&author=P.M.%20Forde&author=J.E.%20Chaft&author=K.N.%20Smith&volume=378&issue=21&publication_year=2018&pages=1976-1986&pmid=29658848&doi=10.1056/NEJMoa1716078&
• How much does https://doi.org/10.1016/j.jtho.2020.01.017 pull in monthly?
• What's the income generated by https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&title=Neoadjuvant%20PD-1%20inhibitor%20(Sintilimab)%20in%20NSCLC&author=S.%20Gao&author=N.%20Li&author=S.%20Gao&volume=15&issue=5&publication_year=2020&pages=816-826&pmid=32036071&doi=10.1016/j.jtho.2020.01.017& each month?
• How much money does https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&title=FP03.02%20interim%20analysis%20of%20neoadjuvant%20chemoradiotherapy%20and%20durvalumab%20for%20potentially%20resectable%20stage%20III%20non-small%20cell%20lung%20cancer%20(NSCLC)&author=M.H.%20Hong&author=B.%20Ahn&author=H.R.%20Kim&volume=16&issue=3&publication_year=2021&pages=S194-S195& make?
• How much income is https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&title=PS01.05%20surgical%20and%20clinical%20outcomes%20with%20neoadjuvant%20atezolizumab%20in%20resectable%20stage%20IB%E2%80%93IIIB%20NSCLC:%20LCMC3%20trial%20primary%20analysis&author=J.%20Lee&author=J.%20Chaft&author=A.%20Nicholas&volume=16&issue=3&publication_year=2021&pages=S59-S61& earning monthly?
• How much revenue does https://doi.org/10.1016/S1470-2045(20)30453-8 generate?
• How much cash flow does https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=Neoadjuvant%20chemotherapy%20and%20nivolumab%20in%20resectable%20non-small-cell%20lung%20cancer%20(NADIM):%20an%20open-label,%20multicentre,%20single-arm,%20phase%202%20trial&author=M.%20Provencio&author=E.%20Nadal&author=A.%20Insa&volume=21&issue=11&publication_year=2020&pages=1413-1422&pmid=32979984&doi=10.1016/S1470-2045(20)30453-8& have monthly?
• How much revenue does https://doi.org/10.1136/jitc-2020-001282 bring in?
• Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=J%C2%A0Immunother%20Cancer&title=Neoadjuvant%20nivolumab%20plus%20ipilimumab%20in%20resectable%20non-small%20cell%20lung%20cancer&author=J.E.%20Reuss&author=V.%20Anagnostou&author=T.R.%20Cottrell&volume=8&issue=2&publication_year=2020&pages=e001282&pmid=32929052&doi=10.1136/jitc-2020-001282&
• How much income does https://doi.org/10.1200/JCO.21.00276 have?
• Profit of https://scholar.google.com/scholar_lookup?journal=J%C2%A0Clin%20Oncol&title=SAKK%2016/14:%20Durvalumab%20in%20addition%20to%20neoadjuvant%20chemotherapy%20in%20patients%20with%20stage%20IIIA(N2)%20non-small-cell%20lung%20cancer:%20a%20multicenter%20single-arm%20phase%20II%20trial&author=S.I.%20Rothschild&author=A.%20Zippelius&author=E.I.%20Eboulet&publication_year=2021&pmid=34251873&doi=10.1200/JCO.21.00276&
• How much profit does https://doi.org/10.21037/jtd-21-103 make?
• See how much https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Dis&title=Neoadjuvant%20pembrolizumab%20with%20chemotherapy%20for%20the%20treatment%20of%20stage%20IIB-IIIB%20resectable%20lung%20squamous%20cell%20carcinoma&author=D.%20Shen&author=J.%20Wang&author=J.%20Wu&volume=13&issue=3&publication_year=2021&pages=1760-1768&pmid=33841966&doi=10.21037/jtd-21-103& makes per month
• How much does https://doi.org/10.1016/S1470-2045(20)30140-6 gross monthly?
• How much does https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=Neoadjuvant%20atezolizumab%20and%20chemotherapy%20in%20patients%20with%20resectable%20non-small-cell%20lung%20cancer:%20an%20open-label,%20multicentre,%20single-arm,%20phase%202%20trial&author=C.A.%20Shu&author=J.F.%20Gainor&author=M.M.%20Awad&volume=21&issue=6&publication_year=2020&pages=786-795&pmid=32386568&doi=10.1016/S1470-2045(20)30140-6& bring in each month?
• https://doi.org/10.1002/cam4.3456's revenue stream
• Learn about the earnings of https://scholar.google.com/scholar_lookup?journal=Cancer%20Med&title=Neoadjuvant%20chemotherapy%20and%20avelumab%20in%20early%20stage%20resectable%20nonsmall%20cell%20lung%20cancer&author=A.%20Tfayli&author=M.%20Al%20Assaad&author=G.%20Fakhri&volume=9&issue=22&publication_year=2020&pages=8406-8411&pmid=32991781&doi=10.1002/cam4.3456&
• https://doi.org/10.1016/j.jtcvs.2021.02.099 income
• How much cash flow does https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Cardiovasc%20Surg&title=Perioperative%20outcomes%20of%20pulmonary%20resection%20after%20neoadjuvant%20pembrolizumab%20in%20patients%20with%20non-small%20cell%20lung%20cancer&author=B.C.%20Tong&author=L.%20Gu&author=X.%20Wang&publication_year=2021&pmid=33985811&doi=10.1016/j.jtcvs.2021.02.099& have monthly?
• Discover the revenue of https://doi.org/10.1016/j.athoracsur.2017.09.030
• How much does https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&title=Surgical%20outcomes%20after%20neoadjuvant%20chemotherapy%20and%20ipilimumab%20for%20non-small%20cell%20lung%20cancer&author=C.J.%20Yang&author=F.%20McSherry&author=N.R.%20Mayne&volume=105&issue=3&publication_year=2018&pages=924-929&pmid=29258674&doi=10.1016/j.athoracsur.2017.09.030& bring in each month?
• What's the income generated by https://doi.org/10.1038/s41591-020-01224-2 each month?
• What is the earnings of https://scholar.google.com/scholar_lookup?journal=Nat%20Med&title=Neoadjuvant%20nivolumab%20or%20nivolumab%20plus%20ipilimumab%20in%20operable%20non-small%20cell%20lung%20cancer:%20the%20phase%202%20randomized%20NEOSTAR%20trial&author=T.%20Cascone&author=W.N.%20William&author=A.%20Weissferdt&volume=27&publication_year=2021&pages=504-514&pmid=33603241&doi=10.1038/s41591-020-01224-2&?
• How much profit does https://doi.org/10.1016/S1470-2045(21)00149-2 generate?
• How much money does https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=Neoadjuvant%20durvalumab%20with%20or%20without%20stereotactic%20body%20radiotherapy%20in%20patients%20with%20early-stage%20non-small-cell%20lung%20cancer:%20a%20single-centre,%20randomised%20phase%202%20trial&author=N.K.%20Altorki&author=T.E.%20McGraw&author=A.C.%20Borczuk&volume=22&issue=6&publication_year=2021&pages=824-835&pmid=34015311&doi=10.1016/S1470-2045(21)00149-2& generate?
• How much revenue does https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&title=62MO%20A%20randomised,%20controlled,%20multicenter%20phase%20II%20trial%20of%20camrelizumab%20combined%20with%20albumin-bound%20paclitaxel%20and%20cisplatin%20as%20neoadjuvant%20treatment%20in%20locally%20advanced%20NSCLC&author=J.%20Lei&author=X.%20Yan&author=J.%20Zhao&author=F.%20Tian&author=Q.%20Lu&volume=31&publication_year=2020&pages=S1441-S1442& bring in?
• How much profit does https://doi.org/10.1016/j.jtho.2020.01.005 generate?
• How much profit does https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&title=IASLC%20multidisciplinary%20recommendations%20for%20pathologic%20assessment%20of%20lung%20cancer%20resection%20specimens%20after%20neoadjuvant%20therapy&author=W.D.%20Travis&author=S.%20Dacic&author=I.%20Wistuba&volume=15&issue=5&publication_year=2020&pages=709-740&pmid=32004713&doi=10.1016/j.jtho.2020.01.005& make?
• How much income does https://doi.org/10.1016/S1470-2045(13)70334-6 have?
• https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&title=Pathological%20response%20after%20neoadjuvant%20chemotherapy%20in%20resectable%20non-small-cell%20lung%20cancers:%20proposal%20for%20the%20use%20of%20major%20pathological%20response%20as%20a%20surrogate%20endpoint&author=M.D.%20Hellmann&author=J.E.%20Chaft&author=W.N.%20William&volume=15&issue=1&publication_year=2014&pages=e42-e50&pmid=24384493&doi=10.1016/S1470-2045(13)70334-6&'s revenue stream
• How much cash flow does https://doi.org/10.1016/j.cllc.2019.11.003 have monthly?
• Monthly income for https://scholar.google.com/scholar_lookup?journal=Clin%20Lung%20Cancer&title=Agreement%20on%20major%20pathological%20response%20in%20NSCLC%20patients%20receiving%20neoadjuvant%20chemotherapy&author=A.%20Weissferdt&author=A.%20Pataer&author=A.A.%20Vaporciyan&volume=21&issue=4&publication_year=2020&pages=341-348&pmid=32279936&doi=10.1016/j.cllc.2019.11.003&
• What is the earnings of https://doi.org/10.1016/j.jtho.2018.11.017?
• https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&title=Pathologic%20assessment%20after%20neoadjuvant%20chemotherapy%20for%20NSCLC:%20importance%20and%20implications%20of%20distinguishing%20adenocarcinoma%20from%20squamous%20cell%20carcinoma&author=Y.%20Qu&author=K.%20Emoto&author=T.%20Eguchi&volume=14&issue=3&publication_year=2019&pages=482-493&pmid=30503889&doi=10.1016/j.jtho.2018.11.017&'s financial summary
• How much profit is https://doi.org/10.1093/narcan/zcaa002 making per month?
• How much does https://scholar.google.com/scholar_lookup?journal=NAR%20Cancer&title=Combined%20cytotoxic%20chemotherapy%20and%20immunotherapy%20of%20cancer:%20modern%20times&author=C.%20Bailly&author=X.%20Thuru&author=B.%20Quesnel&volume=2&issue=1&publication_year=2020&pages=zcca002&pmid=34316682&doi=10.1093/narcan/zcaa002& pull in monthly?
• Get to know what's the income of https://doi.org/10.1200/JCO.2009.27.6204
• How much money does https://scholar.google.com/scholar_lookup?journal=J%C2%A0Clin%20Oncol&title=Preoperative%20chemotherapy%20plus%20surgery%20versus%20surgery%20plus%20adjuvant%20chemotherapy%20versus%20surgery%20alone%20in%20early-stage%20non-small-cell%20lung%20cancer&author=E.%20Felip&author=R.%20Rosell&author=J.A.%20Maestre&volume=28&issue=19&publication_year=2010&pages=3138-3145&pmid=20516435&doi=10.1200/JCO.2009.27.6204& make?
• What is the earnings of https://doi.org/10.1158/2159-8290.CD-18-0099?
• How much money does https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&title=STK11/LKB1%20mutations%20and%20PD-1%20inhibitor%20resistance%20in%20KRAS-mutant%20lung%20adenocarcinoma&author=F.%20Skoulidis&author=M.E.%20Goldberg&author=D.M.%20Greenawalt&volume=8&issue=7&publication_year=2018&pages=822-835&pmid=29773717&doi=10.1158/2159-8290.CD-18-0099& make?
• How much does https://doi.org/10.1158/1078-0432.CCR-17-2005 pull in monthly?
• What's https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=Immune%20activation%20in%20early-stage%20non%E2%80%93small%20cell%20lung%20cancer%20patients%20receiving%20neoadjuvant%20chemotherapy%20plus%20ipilimumab&author=J.S.%20Yi&author=N.%20Ready&author=P.%20Healy&volume=23&issue=24&publication_year=2017&pages=7474-7482&pmid=28951518&doi=10.1158/1078-0432.CCR-17-2005&'s gross income?
• What is the earnings of https://doi.org/10.1016/j.lungcan.2021.01.013?
• https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&title=Surprising%20impact%20of%20stromal%20TIL's%20on%20immunotherapy%20efficacy%20in%20a%20real-world%20lung%20cancer%20study&author=S.%20Hashemi&author=M.F.%20Fransen&author=A.%20Niemeijer&volume=153&publication_year=2021&pages=81-89&pmid=33465698&doi=10.1016/j.lungcan.2021.01.013& income
• Get to know https://doi.org/10.1016/j.lungcan.2021.02.014's earnings
• Get to know what's the income of https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&title=Controversies%20and%20challenges%20in%20the%20pathologic%20examination%20of%20lung%20resection%20specimens%20after%20neoadjuvant%20treatment&author=A.%20Weissferdt&author=A.%20Pataer&author=S.G.%20Swisher&volume=154&publication_year=2021&pages=76-83&pmid=33631448&doi=10.1016/j.lungcan.2021.02.014&
• Get to know https://doi.org/10.18632/oncotarget.26908's earnings
• Discover the revenue of https://scholar.google.com/scholar_lookup?journal=Oncotarget&title=Comparative%20safety%20analysis%20of%20immunotherapy%20combined%20with%20chemotherapy%20versus%20monotherapy%20in%20solid%20tumors:%20a%20meta-analysis%20of%20randomized%20clinical%20trials&author=A.%20Carretero-Gonzalez&author=D.%20Lora&author=I.%20Ghanem&volume=10&issue=35&publication_year=2019&pages=3294-3301&pmid=31143375&doi=10.18632/oncotarget.26908&
• How much income does https://doi.org/10.1186/s40425-017-0300-z have?
• What's the monthly money flow for https://scholar.google.com/scholar_lookup?journal=J%C2%A0Immunother%20Cancer&title=Managing%20toxicities%20associated%20with%20immune%20checkpoint%20inhibitors:%20consensus%20recommendations%20from%20the%20Society%20for%20Immunotherapy%20of%20Cancer%20(SITC)%20Toxicity%20Management%20Working%20Group&author=I.%20Puzanov&author=A.%20Diab&author=K.%20Abdallah&volume=5&issue=1&publication_year=2017&pages=95&pmid=29162153&doi=10.1186/s40425-017-0300-z&?
• Discover the revenue of https://doi.org/10.1200/JCO.2010.33.7089
• Revenue of https://scholar.google.com/scholar_lookup?journal=J%C2%A0Clin%20Oncol&title=Randomized%20phase%20III%20study%20of%20surgery%20alone%20or%20surgery%20plus%20preoperative%20cisplatin%20and%20gemcitabine%20in%20stages%20IB%20to%20IIIA%20non-small-cell%20lung%20cancer&author=G.V.%20Scagliotti&author=U.%20Pastorino&author=J.F.%20Vansteenkiste&volume=30&issue=2&publication_year=2012&pages=172-178&pmid=22124104&doi=10.1200/JCO.2010.33.7089&
• How much does https://doi.org/10.1158/1078-0432.CCR-12-2935 rake in every month?
• What's the income generated by https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&title=The%20clinical%20viewpoint:%20definitions,%20limitations%20of%20RECIST,%20practical%20considerations%20of%20measurement&author=L.C.%20Villaruz&author=M.A.%20Socinski&volume=19&issue=10&publication_year=2013&pages=2629-2636&pmid=23669423&doi=10.1158/1078-0432.CCR-12-2935& each month?
• How much revenue does https://github.com/ncbi produce monthly?
• How much does https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323 net monthly?
• Find out how much https://www.nlm.nih.gov/web_policies.html earns monthly
• How much income does https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office have?
• What's the financial outcome of https://www.hhs.gov/vulnerability-disclosure-policy/index.html?
• How much income does https://support.nlm.nih.gov/?pagename=cloudpmc-viewer%3Apmc%3Aarticle%3Ajournal have?
• What are the earnings of https://www.nlm.nih.gov/accessibility.html?
• What is the monthly revenue of https://www.nlm.nih.gov/careers/careers.html?
• What's the monthly income of https://www.nlm.nih.gov/?
• Profit of https://www.nih.gov/
• How much money does https://www.hhs.gov/ generate?
• How much does https://www.usa.gov/ net monthly?

Analytics and Tracking {📊}

• Google Analytics
• Google Analytics 4
• Google Tag Manager

Libraries {📚}

• jQuery
• jQuery module (jquery-3.6.0)
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• nihcesxway.hub.nih.gov
• nihcesxway2.hub.nih.gov
• nihcesxway3.hub.nih.gov
• nihcesxway4.hub.nih.gov
• nihcesxway5.hub.nih.gov

Name Servers:

• dns1-ncbi.ncbi.nlm.nih.gov
• dns2-ncbi.ncbi.nlm.nih.gov
• lhcns1.nlm.nih.gov
• lhcns2.nlm.nih.gov

CDN Services {📦}

• Ncbi